• Strong revenue growth of 13.3% to $1.7b with all business streams delivering positive organic growth
• Underlying EBIT increased 14.7% to $287.2m, with the underlying EBIT margin strengthening to 17.3%
• Underlying NPAT up by 17.2% to $178.4m

ALS Limited reported a strong set of H1 FY26 results, with revenue growing 13.3% to $1.7 billion and underlying EBIT increasing 14.7% to $287.2 million. The company's underlying EBIT margin strengthened to 17.3%, while underlying NPAT was up 17.2% to $178.4 million. The Commodities division delivered double-digit organic revenue growth, supported by positive market conditions in both Minerals and Industrial Materials. The Life Sciences division also performed well, with robust growth in the Food and Pharmaceutical segments, although the Environmental business faced some challenges in the Americas. ALS continues to drive operational efficiencies and leverage its global footprint to deliver improved financial performance. The company is also focused on unlocking value through the evolution of digital innovation and AI across all business streams, setting the standard for smart labs globally.

ALS expects to deliver double-digit organic revenue growth in both the Commodities and Life Sciences divisions for the full FY26 financial year.

The company remains optimistic about the medium to long-term outlook, with expectations of maintaining its leading market share in the exploration testing market, continued market share growth through the midstream and downstream mining value chain, and resilient margin performance supported by its unique global hub and spoke model. The company also sees strong demand growth opportunities in the energy transition and electrification sectors.